Grannus Therapeutics

Grannus Therapeutics is a biotechnology company that focuses on the development of small molecule inhibitors for specific isoforms of HSP90.

Website: grannustherapeutics.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Lifetech.

Based in: United States.

On Recent Funding since: Sep 28, 2026.

Signals

Website registeredAug 20, 2020 (6 years old)

August 20, 2020
Website created
Date unknown
PPlug and Play · accelerator or program
Source: public.dxp.playbook.vc

JF
John Foglesong Co-Founder & CEO

LinkedIn · source: grannustherapeutics.com
BS
Brian S. J. Blagg Co-Founder & Board Observer

source: grannustherapeutics.com
SM
Sanket Mishra Co-Founder & VP Research

LinkedIn · source: grannustherapeutics.com

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/grannus-therapeutics (get a free API key).